Xiao, Z., Sperl, B., Gärtner, S., Nedelko, T., Stacher-Priehse, E., Ullrich, A., & Knyazev, P. G. (2019). Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach. Oncotarget.

Xiao, Zhiguang, Bianca Sperl, Silvia Gärtner, Tatiana Nedelko, Elvira Stacher-Priehse, Axel Ullrich, e Pjotr G. Knyazev. "Lung Cancer Stem Cells and Their Aggressive Progeny, Controlled By EGFR/MIG6 Inverse Expression, Dictate a Novel NSCLC Treatment Approach." Oncotarget 2019.

Xiao, Zhiguang, et al. "Lung Cancer Stem Cells and Their Aggressive Progeny, Controlled By EGFR/MIG6 Inverse Expression, Dictate a Novel NSCLC Treatment Approach." Oncotarget 2019.